Publication | Closed Access

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial

VaccinationVaccine SafetyCross-protectionVaccine DevelopmentTherapeutic VaccineBiomedical EngineeringInfection ControlVaccine DesignPolyvalent VaccineMedicine